By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706


SEARCH JOBS


Industry
Pharmaceutical

Segment
Oncology





Company News
Spectrum Pharma (SPPI) To Present Corporate Update At The Bank of America (BAC) Merrill Lynch 2016 Healthcare Conference On May 10th 5/3/2016 11:17:34 AM
Spectrum Pharma (SPPI) Announces First Quarter 2016 Financial Results Teleconference And Webcast 4/28/2016 11:14:34 AM
Spectrum Pharma (SPPI) Release: FDA Grants Orphan Drug Exclusivity To EVOMELA (melphalan) For Injection, Indicated For Multiple Myeloma 4/20/2016 11:36:52 AM
Ligand (LGND) Partner Spectrum Pharma (SPPI) Receives FDA Approval Of EVOMELA (Melphalan) For Injection 3/15/2016 10:49:35 AM
FDA Grants Spectrum Pharma (SPPI) Approval Of EVOMELA (Melphalan) For Injection 3/15/2016 10:31:41 AM
Spectrum Pharma (SPPI) Reports Fourth Quarter 2015 And Full Year 2015 Financial Results And Pipeline Update 3/10/2016 10:26:16 AM
Spectrum Pharma (SPPI) Initiates Phase 2 Breast Cancer Trial For Poziotinib, A Novel Pan-HER Inhibitor 3/7/2016 12:14:10 PM
Spectrum Pharma (SPPI) Announces Fourth Quarter And Full Year 2015 Financial Results Teleconference And Webcast 3/2/2016 11:39:43 AM
Spectrum Pharma (SPPI) To Present Corporate Update At 2016 RBC Capital Markets' Global Healthcare Conference On February 24 2/22/2016 11:56:55 AM
Spectrum Pharma (SPPI) Announces FDA’s Acceptance Of NDA Filing For Eoquin (Apaziquone For Intravesical Instillation) 2/19/2016 10:32:08 AM
12345678910...
//-->